» Articles » PMID: 37448670

Detection of Plasmid-mediated AmpC β-lactamases in Clinical Isolates from Bushehr Province, Iran

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Plasmid-mediated AmpC producers are considered an increasing concern. The aim of this study was to investigate the prevalence of plasmid-mediated AmpC β-lactamases (pAmpCs) in isolates.

Materials And Methods: A total of 228 clinical isolates of were collected in Bushehr province, Iran, from December 2017 to February 2019. Cefoxitin disks were applied for screening AmpC-producing isolates. Furthermore, 3 phenotypic confirmatory tests including combine disk test (CDT), double disk synergy test (DDST) and modified three dimensional test (M3DT) were used. Finally, the presence of pAmpC genes was tested by multiplex PCR.

Results: We identified 18 pAmpC-KP isolates among the 228 isolates (7.9%): 12 DHA (66.6%) and 6 CMY (33.3%). In the present study only 47% of cefoxitin-resistant isolates were pAmpC producers. The sensitivity of CDT, DDST, and M3DT was 89%, 67% and 100% and the specificity was 90%, 90% and 85%, respectively. In addition, M3DT displayed a higher rate of efficiency (92%) than CDT (89%) and DDST (79%) in detecting plasmid-meditated AmpC producers.

Conclusion: DHA was the most prevalent pAmpC beta-lactamase in this study. DDST and CDT tests proved inefficient to detect two and six pAmpC producers, respectively, while M3DT represented the best overall performance.

References
1.
Helmy M, Wasfi R . Phenotypic and molecular characterization of plasmid mediated AmpC β-lactamases among Escherichia coli, Klebsiella spp., and Proteus mirabilis isolated from urinary tract infections in Egyptian hospitals. Biomed Res Int. 2014; 2014:171548. PMC: 4070535. DOI: 10.1155/2014/171548. View

2.
Manoharan A, Sugumar M, Kumar A, Jose H, Mathai D, Khilnani G . Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical Centers. Indian J Med Res. 2012; 135:359-64. PMC: 3361873. View

3.
Bauernfeind A, Stemplinger I, Jungwirth R, Giamarellou H . Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother. 1996; 40(1):221-4. PMC: 163087. DOI: 10.1128/AAC.40.1.221. View

4.
Moland E, Black J, Ourada J, Reisbig M, Hanson N, Thomson K . Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob Agents Chemother. 2002; 46(12):3837-42. PMC: 132764. DOI: 10.1128/AAC.46.12.3837-3842.2002. View

5.
Iabadene H, Messai Y, Ammari H, Alouache S, Verdet C, Bakour R . Prevalence of plasmid-mediated AmpC beta-lactamases among Enterobacteriaceae in Algiers hospitals. Int J Antimicrob Agents. 2009; 34(4):340-2. DOI: 10.1016/j.ijantimicag.2009.05.011. View